Abbott receives U.S. FDA approval for new cataract multifocal intraocular lens

DES PLAINES, Illinois — Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) approval for the TECNIS® Multifocal 1-Piece intraocular lens (IOL) for cataract patie...

read more

BINDER innovation prize for Anne Spang

Anne Spang will be presented with the BINDER Innovation Prize at the Annual Meeting of the Society for Cell Biology (DGZ), on 10th March, 2010. The scientist has been awarded the prize for her outstan...

read more

Evolva participates in food ingredient research initiative

Reinach, Switzerland – Evolva Holding SA (SIX: EVE) today announced that its Danish subsidiary has commenced a research initiative focusing on novel ways to produce vanillin and arabinogalactan protei...

read more

Freiburg researchers discover mode of action of insecticidal toxins

In the latest issue of the renowned scientific journal Science (vol. 327, pp. 1139–1142), researchers from the University of Freiburg report on their discovery of a new mode of action of insecticidal ...

read more

Transgene's licencing deal with Novartis disappoints

French biotech firm Transgene SA (TNG.FR) Wednesday said it has entered a licensing deal with Swiss pharmaceutical giant Novartis AG (NVS) for its experimental lung cancer vaccine.

read more

CARBOGEN AMCIS AG names Dr. Mojmir Vavrecka Chief Operating Officer

BUBENDORF, Switzerland — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has appointed Dr. Mojmir Vavrecka a...

read more

Scientists discover causative genetic mutation associated with common inherited neurological disorder

CARLSBAD, Calif. - Scientists using advanced genomic analysis technologies from Life Technologies Corporation (NASDAQ: LIFE) have sequenced an individual's genome and identified the specific causative...

read more

Huntsman to issue senior subordinated notes

THE WOODLANDS, Texas - Huntsman Corporation (NYSE: HUN) today announced its intention, subject to market and other conditions, to privately offer up to $250 million principal amount of senior subordin...

read more

Sanofi-Aventis completes Chattem, Inc acquisition

PARIS - French drug company Sanofi-Aventis (SNY) Thursday said it has completed the acquisition of 100% of Chattem, Inc. (CHTT), which is now a wholly-owned subsidiary of the Sanofi-Aventis Group.

read more

Duquesne University, Agilent Technologies establish mass spectrometry center of excellence to study diseases, environmental issues

PITTSBURGH and SANTA CLARA, Calif. - Duquesne University and Agilent Technologies Inc. (NYSE: A) today announced that they have established a Center of Excellence (COE) for mass spectrometry at the un...

read more

Santhera reports strong 2009 revenues of CHF 22.3m and is financed beyond 2011

LIESTAL, Switzerland - Santhera Pharmaceuticals (SIX: SANN) announced today the financial results for 2009 and updated on the development pipeline.

read more

Actelion announces Full year 2009 financial results

ALLSCHWIL/BASEL, Switzerland - Actelion Ltd (SIX: ATLN) today announced its financial results for the full year 2009. With total net revenues CHF1,772.6 million (FY 2008: CHF 1,473.5 m) and operating ...

read more

Clariant slashes hundreds of jobs in Switzerland

The Clariant specialty chemicals group announced a loss for 2009 on Tuesday and said it would cut 500 jobs, 400 of them in Switzerland.

read more

Galapagos and MorphoSys expand antibody alliance

MECHELEN, Belgium and MARTINSRIED/MUNICH, Germany - Galapagos NV (Euronext: GLPG) and MorphoSys AG (FSE: MOR) announce that they have expanded their antibody alliance in bone & joint diseases.

read more

Novartis oral multiple sclerosis development compound Gilenia (FTY720) granted US priority review status

BASEL, Switzerland - Gilenia®* (FTY720, fingolimod) has been granted priority review status by the US Food and Drug Administration (FDA), which accepted the regulatory submission made in December 2009...

read more

Roche collaborates with Merck on developmental test for cancer-related gene mutation

PLEASANTON, Calif - Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) announced today a research collaboration with Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.) providing Mer...

read more

RIKEN Center for Genomics Medicine chooses Genedata Expressionist for high throughput proteomics R&D

BASEL, Switzerland and TOKJO, Japan - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that the Japanese research foundation RI...

read more

Basilea strikes licensing deal with Astellas

ZURICH - Swiss biotech Basilea struck a licensing deal with Japan's Astellas Pharma, bringing in an upfront payment of 75 million Swiss francs ($70 million) to help ease its cash shortage.

read more

New Novartis CEO targets vaccines, generics buys

BASEL, Switzerland (Reuters) - Joe Jimenez, the new chief executive of Swiss drugmaker Novartis (NOVN.VX), is targeting bolt-on acquisitions as the group digests the multibillion dollar acquisition of...

read more

Polyphor discovers a new class of antibiotics with a novel mode of action

ALLSCHWIL, Switzerland - Today, Polyphor Ltd published the discovery of a new class of antibiotics with a novel mode of action (Science, VOL 327, ISSUE 5968). This proprietary new class of antibiotics...

read more